USD 21.69
(-2.58%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 100.0% |
2022 | -21.61 Million USD | -595.51% |
2021 | 4.36 Million USD | 2.61% |
2020 | 4.25 Million USD | 28.12% |
2019 | 3.31 Million USD | 161.73% |
2018 | 1.26 Million USD | 46.16% |
2017 | 867.36 Thousand USD | -32.76% |
2016 | 1.28 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 239.09 Thousand USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | -100.0% |
2002 | 13 Thousand USD | 119.49% |
2001 | 5925.00 USD | -51.52% |
2000 | 12.22 Thousand USD | -14.5% |
1999 | 14.29 Thousand USD | -36.41% |
1998 | 22.48 Thousand USD | 3.53% |
1997 | 21.71 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q3 | 10.05 Million USD | 1.19% |
2023 Q2 | 9.93 Million USD | 115.34% |
2023 FY | - USD | 100.0% |
2023 Q1 | -64.75 Million USD | -199.6% |
2023 Q4 | - USD | -100.0% |
2022 Q1 | 5.19 Million USD | 19.19% |
2022 FY | -21.61 Million USD | -595.51% |
2022 Q4 | -21.61 Million USD | -419.69% |
2022 Q3 | 6.76 Million USD | 2.1% |
2022 Q2 | 6.62 Million USD | 27.37% |
2021 Q3 | 7.27 Million USD | 9.59% |
2021 Q4 | 4.36 Million USD | -40.05% |
2021 Q2 | 6.63 Million USD | -6.08% |
2021 FY | 4.36 Million USD | 2.61% |
2021 Q1 | 7.06 Million USD | 66.29% |
2020 Q3 | 4.09 Million USD | 33.77% |
2020 FY | 4.25 Million USD | 28.12% |
2020 Q1 | 2.73 Million USD | -17.63% |
2020 Q2 | 3.06 Million USD | 12.04% |
2020 Q4 | 4.25 Million USD | 3.77% |
2019 Q3 | 4.1 Million USD | 133.43% |
2019 Q4 | 3.31 Million USD | -19.14% |
2019 Q1 | 1.55 Million USD | 22.3% |
2019 FY | 3.31 Million USD | 161.73% |
2019 Q2 | 1.75 Million USD | 13.38% |
2018 Q2 | 744.24 Thousand USD | 14.28% |
2018 FY | 1.26 Million USD | 46.16% |
2018 Q3 | 1.09 Million USD | 47.26% |
2018 Q4 | 1.26 Million USD | 15.67% |
2018 Q1 | 651.23 Thousand USD | -24.92% |
2017 Q4 | 867.36 Thousand USD | -6.84% |
2017 FY | 867.36 Thousand USD | -32.76% |
2017 Q3 | 931.04 Thousand USD | 27.22% |
2017 Q2 | 731.83 Thousand USD | 28.52% |
2017 Q1 | 569.41 Thousand USD | -55.86% |
2016 Q2 | - USD | 0.0% |
2016 FY | 1.28 Million USD | 0.0% |
2016 Q4 | 1.28 Million USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | 4.45 Million USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | -100.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q2 | - USD | -100.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | -100.0% |
2011 Q1 | 182.38 Thousand USD | -23.72% |
2011 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | 239.09 Thousand USD | 0.0% |
2010 Q4 | 239.09 Thousand USD | -29.05% |
2010 Q3 | 337 Thousand USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q4 | - USD | -100.0% |
2003 FY | - USD | -100.0% |
2003 Q1 | 13.43 Thousand USD | 3.28% |
2003 Q2 | 13.41 Thousand USD | -0.16% |
2003 Q3 | 13.4 Thousand USD | -0.07% |
2002 FY | 13 Thousand USD | 119.49% |
2002 Q4 | 13 Thousand USD | 5.42% |
2002 Q2 | 5850.00 USD | -0.26% |
2002 Q1 | 5865.00 USD | -1.01% |
2002 Q3 | 12.33 Thousand USD | 110.87% |
2001 FY | 5925.00 USD | -51.52% |
2001 Q1 | 12.04 Thousand USD | -1.47% |
2001 Q2 | 12.03 Thousand USD | -0.05% |
2001 Q4 | 5925.00 USD | -50.15% |
2001 Q3 | 11.88 Thousand USD | -1.25% |
2000 Q3 | 13.59 Thousand USD | -1.52% |
2000 Q4 | 12.22 Thousand USD | -10.11% |
2000 FY | 12.22 Thousand USD | -14.5% |
2000 Q2 | 13.8 Thousand USD | -1.74% |
2000 Q1 | 14.05 Thousand USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 FY | 14.29 Thousand USD | -36.41% |
1998 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 FY | 22.48 Thousand USD | 3.53% |
1997 FY | 21.71 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Xeris Biopharma Holdings, Inc. | 38.83 Million USD | 100.0% |
Codexis, Inc. | 2.68 Million USD | 100.0% |
Viridian Therapeutics, Inc. | - USD | NaN% |
Organovo Holdings, Inc. | 297 Thousand USD | 100.0% |